FIA
AIV

FNY Investment Advisers’s Aimco AIV Stock Holding History

FNY Investment Advisers’s Portfolio AIV Stock Details AIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Buy
16,600
+12,600
+315% +$48.3K 0.02% 418
2026
Q1 		$16K Buy
+4,000
New +$20.9K 0.01% 491
2025
Q4 		– Sell
-20,000
Closed -$158K – 907
2025
Q3 		$158K Buy
+20,000
New +$162K 0.05% 302
2021
Q2 		– Sell
-4,000
Closed -$24K – 765
2021
Q1 		$24K Sell
4,000
-195,000
-98% -$988K 0.01% 503
2020
Q4 		$1.05M Buy
+199,000
New +$884K 0.29% 90

Other funds holding AIV

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
HNB
Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return

FNY Investment Advisers's AIV Position: Q2 2026 in Review

FNY Investment Advisers increased its Aimco (AIV) stake by 315% in Q2 2026, buying an estimated $48.3K and bringing the position to 16,600 shares worth $49K. The position accounts for 0.02% of the portfolio, ranked #418.

FNY Investment Advisers first reported a position in AIV in Q4 2020 and has held it in 5 quarters since. The position peaked at $1.05M in Q4 2020. 6 funds tracked by Wall St. Rank hold AIV as of Q2 2026.

  • FNY Investment Advisers held 16,600 shares of Aimco worth $49K as of Q2 2026.
  • FNY Investment Advisers bought 12,600 Aimco shares in Q2 2026, an estimated $48.3K.
  • Aimco made up 0.02% of FNY Investment Advisers's portfolio in Q2 2026, its #418 holding.
  • FNY Investment Advisers first reported a position in Aimco in Q4 2020 and has held it in 5 quarters since.
  • FNY Investment Advisers's Aimco position peaked at $1.05M in Q4 2020.
  • 6 funds tracked by Wall St. Rank held Aimco as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.